EMG
TEVA icon

Ellington Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Ellington Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,700
Closed -$150K – 392
2020
Q1 		$150K Sell
16,700
-36,471
-69% -$374K 0.04% 470
2019
Q4 		$521K Buy
+53,171
New +$475K 0.11% 160
2019
Q3 		– Sell
-159,480
Closed -$1.47M – 784
2019
Q2 		$1.47M Buy
159,480
+128,780
+419% +$1.55M 0.25% 93
2019
Q1 		$481K Buy
+30,700
New +$541K 0.09% 245
2017
Q4 		– Sell
-18,600
Closed -$327K – 811
2017
Q3 		$327K Buy
+18,600
New +$419K 0.06% 355
2016
Q4 		– Sell
-9,400
Closed -$432K – 796
2016
Q3 		$432K Buy
+9,400
New +$490K 0.12% 328
2015
Q2 		– Sell
-5,000
Closed -$312K – 876
2015
Q1 		$312K Buy
5,000
+200
+4% +$11.6K 0.06% 456
2014
Q4 		$276K Buy
+4,800
New +$267K 0.09% 357
2014
Q3 		– Sell
-4,100
Closed -$215K – 464
2014
Q2 		$215K Buy
+4,100
New +$210K 0.1% 334
2013
Q3 		– Sell
-9,100
Closed -$357K – 969
2013
Q2 		$357K Buy
+9,100
New +$354K 0.07% 444

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's TEVA Position: Q2 2020 in Review

Ellington Management Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 16,700 shares — an estimated $150K sold.

Ellington Management Group first reported a position in TEVA in Q2 2013 and held it in 10 quarters. The position peaked at $1.47M in Q2 2019. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Ellington Management Group reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 16,700 Teva Pharmaceuticals shares in Q2 2020, an estimated $150K.
  • Ellington Management Group first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Ellington Management Group's Teva Pharmaceuticals position peaked at $1.47M in Q2 2019.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.